NEOPLASMS, LUNG

Clinical trials for NEOPLASMS, LUNG explained in plain language.

Never miss a new study

Get alerted when new NEOPLASMS, LUNG trials appear

Sign up with your email to follow new studies for NEOPLASMS, LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1 Terminated 1

New drug targets Hard-to-Treat cancers with KRAS mutation

Disease control Ongoing

This study tests a new drug called JDQ443, alone or with other treatments, for people with advanced solid tumors that have a specific genetic change called KRAS G12C. The goal is to find the safest dose and see if the drug can shrink tumors. About 344 adults whose cancer has not …

Matched conditions: NEOPLASMS, LUNG

Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 11:03 UTC

NEOPLASMS, LUNG

Get alerted when new NEOPLASMS, LUNG trials appear

New drug targets Hard-to-Treat cancers with KRAS mutation